Bratman, Scott

Biography

Dr. Scott V. Bratman is Scientist at Princess Margaret Cancer Centre and Assistant Professor of Radiation Oncology and Medical Biophysics at the University of Toronto. Dr. Bratman also serves as Staff Radiation Oncologist and Clinician-Scientist in the Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network. Dr. Bratman received his MD and PhD degrees from Columbia University in 2009. He was trained in radiation oncology at the Stanford Cancer Institute, where he performed postdoctoral research studies with Drs. Max Diehn and Ash Alizadeh. Since his arrival in Toronto in September 2014, his primary research focus has been on improving outcomes for patients with head and neck cancer and other cancers through optimized detection and personalized treatments. Dr. Bratman's laboratory is currently developing and validating blood-based biomarkers for detecting and monitoring the presence of cancer. The team is also interested in leveraging tumor genomics data to improve upon curative treatment approaches for head and neck cancers. Dr. Scott V. Bratman is Scientist at Princess Margaret Cancer Centre and Assistant Professor of Radiation Oncology and Medical Biophysics at the University of Toronto. Dr. Bratman also serves as Staff Radiation Oncologist and Clinician-Scientist in the Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network. Dr. Bratman received his MD and PhD degrees from Columbia University in 2009. He was trained in radiation oncology at the Stanford Cancer Institute, where he performed postdoctoral research studies with Drs. Max Diehn and Ash Alizadeh. Since his arrival in Toronto in September 2014, his primary research focus has been on improving outcomes for patients with head and neck cancer and other cancers through optimized detection and personalized treatments. Dr. Bratman's laboratory is currently developing and validating blood-based biomarkers for detecting and monitoring the presence of cancer. The team is also interested in leveraging tumor genomics data to improve upon curative treatment approaches for head and neck cancers.

Research Interest

A strong focus of the lab is on circulating tumor-derived DNA (ctDNA) and its utility and applications as a cancer biomarker. The lab also focuses on head and neck cancer genomics and translational research, stemming from Dr. Bratman’s clinical focus. Methodologies frequently employed in the lab include in vitro and in vivo models of head and neck cancer, quantitative and digital PCR, next-generation sequencing technologies, and mining of publicly available genomics data. The lab seeks to apply concepts of precision/personalized cancer medicine to the use of radiotherapy in curative treatment settings.